Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 5/20 | 0.80 |
| ▸ | PLG | P00747 | 4/20 | 0.80 |
| ▸ | CHEK2 | O96017 | 8/20 | 0.73 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20912442 | 0.99 | PLAU (0.77) | PLAUPLGCHEK2PRSS1MEN1 | |
| SCHEMBL5517426 | 0.92 | PLAU (0.83) | PLAUPLGPRSS1 | |
| SCHEMBL24312880 | 0.90 | PLAU (0.81) | PLAUPLGCHEK2PRSS1 | |
| SCHEMBL14519390 | 0.90 | PLAU (0.86) | PLAUPLGPRSS1 | |
| SCHEMBL12348362 | 0.89 | PLAU (0.79) | PLAUPLGPRSS1 | |
| SCHEMBL14355116 | 0.89 | PLAU (0.83) | PLAUPLGCHEK2PRSS1 | |
| SCHEMBL14519369 | 0.86 | PLAU (0.74) | PLAUPLGCHEK2PRSS1 | |
| SCHEMBL13167159 | 0.86 | PLAU (0.71) | PLAUPLGCHEK2PRSS1 | |
| SCHEMBL14599555 | 0.85 | PLAU (0.77) | PLAUPLGCHEK2PRSS1 | |
| SCHEMBL20912411 | 0.84 | PLAU (0.91) | PLAUPLGCHEK2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107113-A1 | MODIFIED CELLS FOR PROGRAMMING EXTRA ENVELOPED VIRUSES (EEVs) AND THEIR USE FOR PRODUCING THE EEVs, THE PROGRAMMED EEVs AND USES THEREOF | CALIDI BIOTHERAPEUTICS (NEVADA), INC. (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026107113-A1 | MODIFIED CELLS FOR PROGRAMMING EXTRA ENVELOPED VIRUSES (EEVs) AND THEIR USE FOR PRODUCING THE EEVs, THE PROGRAMMED EEVs AND USES THEREOF | CALIDI BIOTHERAPEUTICS (NEVADA), INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| CN-119895035-A | Thermostable reverse transcriptase and application thereof | 深圳华大生命科学研究院 | 2025-04-25 | — | — | CN | disclosed |
| CN-113785053-B | Reverse transcriptase with increased enzymatic activity and use thereof | 深圳华大生命科学研究院 | 2024-07-12 | — | — | CN | disclosed |
| WO-2024092768-A1 | THERMOSTABLE REVERSE TRANSCRIPTASE AND USE THEREOF | 深圳华大生命科学研究院 | 2024-05-10 | — | — | WO | disclosed |